查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2011687

大腿穿刺器材市場：依器械類型、鞘套尺寸、材質、應用和最終用戶分類－2026-2032年全球市場預測

Femoral Access Devices Market by Device Type, Sheath Size, Material, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，大腿入路裝置市場價值將達到 21.7 億美元，到 2026 年將成長至 24.1 億美元，到 2032 年將達到 46.6 億美元，複合年成長率為 11.49%。

主要市場統計數據
基準年 2025 21.7億美元
預計年份：2026年 24.1億美元
預測年份 2032 46.6億美元
複合年成長率 (%) 11.49%

概述不斷發展的股動脈通路裝置市場，其中臨床需求、裝置創新和營運重點塑造了策略選擇。

股動脈入路器械市場正經歷持續的演變，其驅動力包括手術複雜性的增加、器械的創新以及醫療系統需求的不斷成長。臨床醫生越來越需要能夠提高手術精準度並最大限度減少併發症的工具，而製造商也在調整產品系列和材料以滿足這些期望。同時，不斷變化的報銷機制、品質指標和醫院籌資策略也在影響門診手術中心、診所和醫院的採購行為。因此，整個價值鏈上的相關人員必須平衡臨床優先事項和營運效率，以改善患者預後並減少術中和術後併發症。

不斷發展的臨床實踐、聚合物和塗層技術的創新以及醫療保健服務格局的變化，是如何重新定義醫療設備設計重點和採購實踐的？

股動脈入路器械領域正經歷一系列變革，其驅動力包括臨床實踐的轉變、技術的進步以及對手術全期安全性的日益重視。在心血管外科、神經外科、放射外科和血管外科領域，外科醫師擴大採用微創手術方式，因此，器械的設計重點也隨之轉向體積更小、止血控制更佳、且能與影像和導航系統無縫整合的器械。因此，設計重點正轉向親水塗層、高度適應性的閥門系統以及能夠減少動脈損傷並與更多手術器械相容的鞘套形狀。

評估 2025 年關稅政策和貿易趨勢的變化將如何重塑籌資策略、價格談判和供應鏈韌性方面的決策。

2025年，貿易政策的變化和關稅措施的實施，為採購股動脈通路裝置及其組件的機構帶來了新的複雜性。針對醫療設備進口、組件和聚合物原料的關稅調整，改變了部分製造商和經銷商的成本結構，尤其是那些供應鏈依賴跨境製造地。這些變化迫使下游相關人員重新評估其籌資策略、庫存緩衝和供應商多元化，以降低成本突然上漲的風險。

高解析度分割分析揭示了設備結構、鞘套尺寸、臨床應用、終端用戶環境和材料科學如何共同推動其普及應用。

為了解細分市場的效能，必須詳細檢視器材類別、鞘套尺寸、臨床應用、終端使用者環境和材料選擇。這些因素都是獨特採購邏輯和臨床價值提案背後的驅動力。根據器械類型，市場可細分為擴張器、導管導引線、止血閥和導引鞘，並進行相應研究。在擴張器方面，多腔和單腔配置的差異會影響交換效率和器械相容性；而導管導引線的亞型，例如親水性塗層、J型尖端和直型尖端，則決定了其導航特性和血管通路策略。止血閥的選擇，從親水閥到機械閥，直接影響出血控制和手術操作的可行性。導引鞘按10Fr及以上、6Fr及以下和7Fr至9Fr分類，反映了與手術器械的兼容性和血管損傷方面的考慮。

區域趨勢和策略性洞察揭示了影響全球主要地區採用趨勢的獨特還款、監管和基礎設施因素。

股動脈通路器械領域的區域趨勢反映了美洲、歐洲、中東和非洲以及亞太地區醫療保健系統結構、法規環境和投資重點的差異。在美洲，成熟的介入性心臟病學和血管外科項目，加上健全的報銷機制，支持了先進器械功能和打包服務模式的早期應用。該地區對臨床結果和基於價值的採購的重視，促使供應商支持長期臨床研究，以檢驗器械能夠降低併發症率，並在真實臨床環境中驗證其性能。

這份競爭格局分析報告詳細闡述了塗層、閥門設計和整合服務交付方面的創新如何影響供應商差異化和合作夥伴關係。

股動脈入路器材領域的競爭格局正在重塑，企業更加重視產品創新、策略夥伴關係和供應鏈的穩定性。領先的器械開發商正優先研發差異化技術，例如先進的親水塗層、精密的止血閥設計以及旨在減少動脈損傷的最佳化鞘套形狀，以贏得介入外科醫生的支持。許多公司也在拓展服務範圍，包括外科訓練、手術流程清單和數據驅動的療效支援。這些措施有助於加速產品推廣應用，並提升臨床提案。

制定可操作的策略重點，整合產品創新、製造韌性、與臨床醫生的合作以及靈活的契約，以確保永續的市場領導地位。

產業領導企業應採取協作策略，將產品創新、供應鏈韌性和臨床療效證據結合。優先投資於能夠顯著減少血管損傷並提高器械操作性的材料和塗層技術，並將這些創新與嚴格的上市後數據收集相結合，以檢驗臨床益處。在與以結果為導向的採購委員會和支付相關人員溝通時，證明併發症率降低和工作流程簡化至關重要。

結合對臨床醫生的訪談、對監管和臨床證據的審查以及情境分析，採用穩健的混合方法研究途徑，可以產生檢驗的策略見解。

本研究整合了多項證據，以確保結論既有主要研究結果的支持，也有次要檢驗。主要資訊來源包括對循環系統、神經病學、放射學和血管外科介入臨床醫生、醫院和門診中心的採購和供應鏈經理以及醫療設備製造商的研發主管進行的結構化訪談。這些訪談旨在深入了解醫療醫療設備效能、採購重點、臨床工作流程限制以及供應鏈薄弱環節等方面的實際問題。

透過整合核心研究成果並制定強調臨床檢驗、供應鏈敏捷性和商業性可行性的策略藍圖，我們正在推動永續應用。

股動脈通路器材市場正處於技術進步、臨床需求和商業策略交會的十字路口。材料和器材結構的進步使得更安全、更有效率的通路技術成為可能，而醫療保健格局和採購模式的改變正在改變器材的採購和部署方式。同時，貿易政策趨勢和供應鏈壓力凸顯了製造敏捷性和商業性柔軟性的必要性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：大腿入路器材市場：依器材類型分類

  • 擴充器
    • 多流明
    • 單流明
  • 導管導引線
    • 親水塗層
    • J 型尖端
    • 直尖
  • 止血瓣
    • 親水閥
    • 機械閥
  • 導引鞘
    • 10Fr 或更高
    • 6Fr 或更少
    • 7Fr～9Fr

第9章：以鞘套尺寸分類的大腿入路裝置市場

  • 10Fr 或更高
  • 6Fr 或更少
  • 7Fr～9Fr

第10章：大腿入路器材市場：依材料分類

  • 尼龍
    • 單絲尼龍
    • 多絲纖維龍
  • 聚氨酯
    • 聚酯聚氨酯
    • 醚聚氨酯
  • PTFE
    • 發泡聚四氟乙烯
    • 標準聚四氟乙烯

第11章：大腿入路裝置市場：依應用領域分類

  • 循環系統
    • 診斷性血管造影術
    • 介入性心臟病學
  • 神經病學
    • 神經影像學
    • 介入神經放射學
  • 放射科
    • 診斷放射學
    • 介入放射學
  • 血管外科
    • EVAR
    • 周邊血管成形術

第12章 大腿入路裝置市場：依最終用戶分類

  • 門診手術中心
    • 心臟外科手術中心
    • 放射科門診手術中心
  • 診所
    • 門診部
    • 專科診所
  • 醫院
    • 心臟病醫院
    • 綜合醫院

第13章：大腿入路器材市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 大腿入路器材市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：大腿入路器材市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國大腿入路器材市場

第17章：中國大腿入路器材市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • AngioDynamics Inc.
  • Argon Medical Devices Inc.
  • B. Braun Melsungen AG
  • Becton Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health Inc.
  • Cook Medical LLC
  • Cordis Corporation
  • Edwards Lifesciences Corporation
  • Galt Medical Corp.
  • Lepu Medical Technology Inc.
  • Medikit Co. Ltd.
  • Medline Industries LP
  • Medtronic plc
  • Merit Medical Systems Inc.
  • Nipro Medical Corporation
  • Romsons Scientific & Surgical Pvt. Ltd.
  • Smiths Medical
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
  • Vascular Solutions Inc.
  • Vygon SA
Product Code: MRR-43676CF42AF7

The Femoral Access Devices Market was valued at USD 2.17 billion in 2025 and is projected to grow to USD 2.41 billion in 2026, with a CAGR of 11.49%, reaching USD 4.66 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.17 billion
Estimated Year [2026] USD 2.41 billion
Forecast Year [2032] USD 4.66 billion
CAGR (%) 11.49%

A concise orientation to the evolving femoral access devices landscape where clinical demand, device innovation, and operational priorities are shaping strategic choices

The femoral access devices landscape is undergoing a period of sustained evolution as procedural complexity, device innovation, and health system imperatives converge. Clinicians increasingly demand tools that enhance procedural precision while minimizing complications, and manufacturers are adapting product portfolios and materials to meet these expectations. In parallel, evolving reimbursement frameworks, quality metrics, and hospital procurement strategies are shaping purchasing behavior across ambulatory surgical centers, clinics, and hospitals. Consequently, stakeholders across the value chain must reconcile clinical priorities with operational efficiency to deliver improved patient outcomes and reduce peri-procedural morbidity.

Today's clinical decision-making is influenced by a combination of procedural efficacy, device ergonomics, and evidence generated from interventional cardiology, radiology, neurology, and vascular surgery. As a result, product differentiation is less about incremental features and more about demonstrable clinical value, streamlined workflows, and compatibility with a broader ecosystem of interventional equipment. In response, device developers are investing in materials science, hydrophilic coatings, and refined valve and sheath architectures that respond to both clinician preferences and safety imperatives. These advances are creating new expectations for device performance, driving competitive repositioning, and prompting end users to scrutinize total cost of care implications rather than unit price alone.

Looking ahead, market participants must balance innovation with regulatory rigor and supply chain resilience. Clinical adoption will depend on robust evidence, ease of use in variable care settings, and demonstrable reductions in complication rates. Meanwhile, procurement teams will prioritize predictable supply, scalable vendor relationships, and products that enable shorter procedure times and faster patient throughput. This introduction frames a sector in transition, one where strategic investments in product performance, stakeholder engagement, and operational readiness will determine which organizations capture sustainable clinical adoption and payer support.

How clinical practice evolution, polymer and coating innovations, and care setting shifts are redefining device design priorities and procurement behaviors

The femoral access devices sector is experiencing a series of transformative shifts driven by clinical practice changes, technological advances, and heightened emphasis on perioperative safety. Operators are increasingly adopting minimally invasive approaches across cardiology, neurology, radiology, and vascular surgery, which places a premium on smaller profiles, improved hemostasis control, and devices that integrate seamlessly with imaging and guidance systems. As a result, design priorities have shifted toward hydrophilic coatings, adaptable valve systems, and sheath geometries that reduce arterial trauma and support a wider range of procedural instruments.

Simultaneously, material innovation is reshaping product lifecycles. Nylon, polyurethane, and PTFE variants are being reformulated to balance pushability, kink resistance, and biocompatibility. These material optimizations are enabling more reliable introducer sheaths and dilators that perform consistently across diverse patient anatomies. In turn, suppliers are reallocating R&D resources toward polymer chemistry and coating technologies that can deliver both tactile responsiveness and reduced complication rates. The emergence of multi-lumen dilators and specialized guidewire tip configurations reflects an ongoing trend toward task-specific instruments that enhance procedural control and reduce exchange-related risks.

Operationally, the shift toward ambulatory and hybrid care settings is prompting changes in device distribution and service models. Ambulatory surgical centers and outpatient specialty clinics demand kits and device bundles that simplify inventory management and reduce setup time. Consequently, manufacturers are exploring value-added services such as vendor-managed inventory, surgical training programs, and digital tools for device tracking and clinical outcomes monitoring. These shifts are also encouraging strategic partnerships between device companies and healthcare providers to co-develop protocols that standardize access strategies and promote consistent outcomes. As these trends coalesce, the competitive landscape will favor organizations that can demonstrate clinical effectiveness, operational convenience, and an ability to reduce overall peri-procedural risk.

Assessment of how evolving tariff policies and trade dynamics in 2025 are reshaping sourcing strategies, pricing negotiations, and supply chain resilience decisions

In 2025, changes in trade policy and tariff implementations have introduced new layers of complexity for organizations sourcing femoral access devices and components. Tariff adjustments targeting medical device imports, components, and raw polymer inputs have altered cost structures for certain manufacturers and distributors, particularly those with supply chains oriented toward cross-border manufacturing hubs. These shifts have compelled downstream stakeholders to reassess sourcing strategies, inventory buffers, and supplier diversification to mitigate exposure to sudden cost transference.

For manufacturers that import critical materials such as specialized polymers, PTFE variants, and hydrophilic coating chemicals, tariffs have translated into higher input costs and, in some cases, a re-evaluation of production footprints. As a result, several firms are accelerating nearshoring initiatives and vendor consolidation to preserve margin and reduce lead-time variability. At the same time, procurement teams within hospitals and ambulatory surgical centers are pushing for greater transparency around landed costs and total cost of ownership, challenging suppliers to provide clearer breakdowns of price drivers and to demonstrate cost-saving value across the care continuum.

The cumulative impact has also influenced strategic pricing and contract negotiations. Large integrated health systems are leveraging purchasing scale to seek fixed-price multi-year agreements that hedge against further tariff volatility, while smaller providers are prioritizing flexible procurement arrangements that allow for rapid substitution or switching to alternative product lines. Moreover, the tariff environment has accelerated conversation around product localization, with some original equipment manufacturers investing in regional manufacturing capabilities to reduce tariff exposure and improve supply chain resilience. These changes are prompting legal, regulatory, and commercial teams to collaborate more closely to align sourcing decisions with evolving trade conditions and to protect continuity of care.

High-resolution segmentation analysis revealing how device architecture, sheath dimensions, clinical application, end-user setting, and material science collectively drive adoption

Understanding segment-level performance requires a granular look at device categories, sheath dimensions, clinical applications, end-user settings, and material selection, each of which drives distinct purchasing logic and clinical value propositions. Based on device type, the market is studied across dilator, guidewire, hemostasis valve, and introducer sheath; within dilators, the distinction between multi-lumen and single lumen configurations informs exchange efficiency and device compatibility, while guidewire subtypes such as hydrophilic coated, J tip, and straight tip determine navigation characteristics and vessel access strategy. Hemostasis valve options ranging from hydrophilic valves to mechanical valves directly affect blood loss management and procedural ergonomics, and introducer sheaths segmented into 10Fr & above, 6Fr & below, and 7Fr-9Fr reflect procedural instrument compatibility and vessel trauma considerations.

Sheath size segmentation similarly frames clinical decision-making; 10Fr & above profiles are often selected for complex interventional procedures requiring larger device platforms, whereas 6Fr & below profiles support diagnostic angiography and less invasive interventions, with 7Fr-9Fr representing a compromise between access trauma and device compatibility. Application-based segmentation highlights the interplay between device features and clinical workflows across cardiology, neurology, radiology, and vascular surgery. Cardiology use encompasses diagnostic angiography and interventional cardiology where rapid hemostasis and sheath maneuverability are prioritized. Neurology covers neuroimaging and neurointervention, emphasizing atraumatic navigation and compatibility with neurovascular devices. Radiology spans diagnostic and interventional radiology with diverse sheath and guidewire requirements, and vascular surgery includes EVAR and peripheral angioplasty procedures where device robustness and seal integrity are critical.

End-user segmentation differentiates adoption dynamics across ambulatory surgical centers, clinics, and hospitals. Ambulatory surgical centers are further profiled into cardiac and radiology ASCs that demand streamlined kits and predictable supply, clinics are split into outpatient and specialty clinics that prioritize cost-effectiveness and ease of use, and hospitals are categorized into cardiac hospitals and multispecialty hospitals where procurement decisions balance volume-based contracts with clinical trial-driven adoption. Material segmentation captures the role of polymer science in device performance. Nylon variants, including monofilament and multifilament forms, offer differing tensile properties and tactile feedback. Polyurethane subtypes such as ester and ether formulations balance flexibility and chemical resistance, while PTFE options, comprising expanded and standard PTFE, contribute to lubricity and reduced friction. Together, these segmentations reveal how product architecture, sizing, clinical context, care setting, and material properties jointly determine specification choices, purchasing criteria, and adoption curves.

Regional dynamics and strategic considerations showing how distinct reimbursement, regulatory, and infrastructure factors are influencing adoption across key global regions

Regional dynamics in the femoral access devices sector reflect divergent healthcare system structures, regulatory environments, and investment priorities across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, established interventional cardiology and vascular surgery programs paired with robust reimbursement frameworks support early adoption of advanced device features and bundled service models. This region's focus on clinical outcomes and value-based procurement encourages suppliers to demonstrate reductions in complication rates and to support long-term clinical studies that validate device performance in real-world settings.

Across Europe, the Middle East & Africa, regulatory harmonization efforts and public procurement mechanisms shape purchasing cycles and product registration strategies. Hospitals and health authorities in many markets emphasize cost containment and standardized device formularies, fostering demand for devices that combine clinical efficacy with demonstrable cost benefits. In addition, regional centers of excellence in interventional neurology and radiology drive innovation adoption in higher-acuity sites, influencing vendor positioning and partnership models.

The Asia-Pacific region is characterized by heterogeneous market maturity and rapid capacity expansion in diagnostic and interventional services. Investments in new hospital infrastructure, growth in ambulatory surgical centers, and a rising prevalence of cardiovascular and neurovascular procedures are motivating accelerated uptake of femoral access technologies. Meanwhile, local manufacturing capabilities and policy incentives for domestic production are prompting multinational firms to adapt supply chain footprints and to pursue collaborative ventures. Collectively, these regional trends shape how suppliers prioritize product launches, clinical education programs, and commercial strategies to meet diverse regulatory and end-user expectations.

Competitive landscape insights detailing how innovation in coatings, valve design, and integrated service offerings are shaping vendor differentiation and alliances

Competitive positioning in the femoral access devices arena is being redefined by product innovation, strategic partnerships, and a renewed emphasis on supply continuity. Leading device developers are prioritizing differentiated technologies-such as advanced hydrophilic coatings, refined hemostasis valve designs, and sheath geometries optimized for reduced arterial trauma-to secure preference among interventionalists. Many firms are also expanding their service portfolios to include surgeon training, procedural checklists, and data-driven outcomes support that facilitate adoption and reinforce clinical value propositions.

Strategic collaborations between device manufacturers and clinical centers are increasingly common, enabling co-development of protocolized access approaches and post-market surveillance programs. These alliances help demonstrate real-world performance while creating pathways for incremental product enhancement. At the same time, some companies are pursuing operational initiatives to shore up manufacturing resilience, including localized production and diversified supplier relationships for critical polymers and coating chemistries. Such measures are essential to mitigate supply disruptions and to preserve contract commitments under evolving tariff regimes.

Finally, the competitive landscape is shaped by the capacity to provide integrated solutions that reduce hospital inventory complexity and improve procedural throughput. Organizations that can bundle compatible dilators, guidewires, hemostasis valves, and sheaths into clinician-friendly kits, while supporting them with training and outcomes data, are likely to secure stronger in-market traction. Success will hinge on demonstrating that these integrated offerings deliver measurable improvements in procedural efficiency, safety, and clinician satisfaction.

Actionable strategic priorities to synchronize product innovation, manufacturing resilience, clinician engagement, and flexible contracting to secure durable market leadership

Industry leaders should pursue a coordinated strategy that aligns product innovation with supply chain resilience and clinical outcomes evidence. First, prioritize investments in materials and coating technologies that demonstrably reduce vascular trauma and improve device handling, and couple those innovations with rigorous post-market data collection to validate clinical benefits. Demonstrating reduced complication rates and workflow efficiencies will be pivotal when engaging with outcome-focused procurement committees and payer stakeholders.

Second, diversify manufacturing footprints and secure alternative suppliers for critical raw materials to reduce exposure to tariff-driven cost volatility and geopolitical disruptions. Nearshoring or regional manufacturing partnerships can shorten lead times and support longer-term commercial contracts with large health systems. Third, develop clinician-centric delivery models by offering procedure-specific kits, hands-on training programs, and digital tools that track device utilization and clinical outcomes. These initiatives will lower the barriers to adoption in ambulatory and outpatient settings while building long-term clinician loyalty.

Fourth, emphasize commercial flexibility by offering tiered pricing, multi-year supply agreements, and outcome-linked contracting where feasible. This will enable purchasers to manage cost uncertainty and to align incentives across stakeholders. Finally, invest in targeted regional strategies that respect local regulatory dynamics and care delivery models; in some regions this will require partnerships with domestic manufacturers or tailored clinical evidence packages that speak to regional practice patterns. By executing on these priorities, industry leaders can strengthen market positioning, protect margins, and expand clinical adoption across diverse care settings.

Robust mixed-methods research approach combining clinician interviews, regulatory and clinical evidence review, and scenario analysis to produce validated strategic insights

This research synthesizes multiple streams of evidence to ensure conclusions are grounded in both primary insight and secondary validation. Primary inputs include structured interviews with interventional clinicians across cardiology, neurology, radiology, and vascular surgery, procurement and supply chain leaders at hospitals and ambulatory centers, and R&D executives at device manufacturers. These engagements were designed to elicit practical perspectives on device performance, procurement priorities, clinical workflow constraints, and supply chain sensitivities.

Secondary research encompassed a systematic review of peer-reviewed clinical literature, regulatory approvals and safety communications, patent filings, and publicly available corporate disclosures that illuminate product pipelines and commercial strategies. Where available, clinical registries and procedure outcome repositories were consulted to triangulate claims regarding device safety and efficacy. The methodology emphasized cross-validation between clinician-reported experiences and documented clinical evidence to reduce bias and improve the reliability of insights.

Analytic techniques included comparative feature mapping across device segments, scenario analysis for tariff and supply chain impacts, and qualitative synthesis to derive actionable recommendations. Care was taken to maintain transparency around data sources and to qualify insights where evidence was limited or evolving. This approach ensures that findings are both actionable for commercial stakeholders and sufficiently rigorous for clinical audiences seeking evidence-aligned guidance.

Synthesis of core findings and a strategic roadmap emphasizing clinical validation, supply chain agility, and commercial alignment to drive sustained adoption

The femoral access devices landscape is at an inflection point where technical refinement, clinical priorities, and commercial strategy intersect. Advances in materials and device architecture are enabling safer, more efficient access techniques, while changing care settings and procurement models are reshaping how devices are purchased and deployed. At the same time, trade policy developments and supply chain pressures underscore the need for manufacturing agility and commercial flexibility.

Success in this environment will depend on a disciplined focus on three intertwined objectives: delivering measurable clinical value through innovation and evidence generation, securing supply chain robustness to ensure uninterrupted access to critical components, and aligning commercial models with purchaser expectations around outcomes and total cost of care. Organizations that can operationalize these objectives-by combining product differentiation with clinician engagement and flexible contracting-will be best positioned to capture sustained adoption across hospitals, ambulatory centers, and specialty clinics. The recommendations offered herein provide a practical roadmap to navigate the near-term challenges and to capitalize on long-term opportunities within the sector.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Femoral Access Devices Market, by Device Type

  • 8.1. Dilator
    • 8.1.1. Multi-Lumen
    • 8.1.2. Single Lumen
  • 8.2. Guidewire
    • 8.2.1. Hydrophilic Coated
    • 8.2.2. J Tip
    • 8.2.3. Straight Tip
  • 8.3. Hemostasis Valve
    • 8.3.1. Hydrophilic Valve
    • 8.3.2. Mechanical Valve
  • 8.4. Introducer Sheath
    • 8.4.1. 10Fr & Above
    • 8.4.2. 6Fr & Below
    • 8.4.3. 7Fr-9Fr

9. Femoral Access Devices Market, by Sheath Size

  • 9.1. 10Fr & Above
  • 9.2. 6Fr & Below
  • 9.3. 7Fr-9Fr

10. Femoral Access Devices Market, by Material

  • 10.1. Nylon
    • 10.1.1. Monofilament Nylon
    • 10.1.2. Multifilament Nylon
  • 10.2. Polyurethane
    • 10.2.1. Ester Polyurethane
    • 10.2.2. Ether Polyurethane
  • 10.3. PTFE
    • 10.3.1. Expanded PTFE
    • 10.3.2. Standard PTFE

11. Femoral Access Devices Market, by Application

  • 11.1. Cardiology
    • 11.1.1. Diagnostic Angiography
    • 11.1.2. Interventional Cardiology
  • 11.2. Neurology
    • 11.2.1. Neuroimaging
    • 11.2.2. Neurointervention
  • 11.3. Radiology
    • 11.3.1. Diagnostic Radiology
    • 11.3.2. Interventional Radiology
  • 11.4. Vascular Surgery
    • 11.4.1. EVAR
    • 11.4.2. Peripheral Angioplasty

12. Femoral Access Devices Market, by End User

  • 12.1. Ambulatory Surgical Center
    • 12.1.1. Cardiac ASC
    • 12.1.2. Radiology ASC
  • 12.2. Clinic
    • 12.2.1. Outpatient Clinic
    • 12.2.2. Specialty Clinic
  • 12.3. Hospital
    • 12.3.1. Cardiac Hospital
    • 12.3.2. Multispecialty Hospital

13. Femoral Access Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Femoral Access Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Femoral Access Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Femoral Access Devices Market

17. China Femoral Access Devices Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. AngioDynamics Inc.
  • 18.7. Argon Medical Devices Inc.
  • 18.8. B. Braun Melsungen AG
  • 18.9. Becton Dickinson and Company
  • 18.10. Boston Scientific Corporation
  • 18.11. Cardinal Health Inc.
  • 18.12. Cook Medical LLC
  • 18.13. Cordis Corporation
  • 18.14. Edwards Lifesciences Corporation
  • 18.15. Galt Medical Corp.
  • 18.16. Lepu Medical Technology Inc.
  • 18.17. Medikit Co. Ltd.
  • 18.18. Medline Industries LP
  • 18.19. Medtronic plc
  • 18.20. Merit Medical Systems Inc.
  • 18.21. Nipro Medical Corporation
  • 18.22. Romsons Scientific & Surgical Pvt. Ltd.
  • 18.23. Smiths Medical
  • 18.24. Stryker Corporation
  • 18.25. Teleflex Incorporated
  • 18.26. Terumo Corporation
  • 18.27. Vascular Solutions Inc.
  • 18.28. Vygon SA

LIST OF FIGURES

  • FIGURE 1. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL FEMORAL ACCESS DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL FEMORAL ACCESS DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY SHEATH SIZE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES FEMORAL ACCESS DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA FEMORAL ACCESS DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DILATOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DILATOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DILATOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DILATOR, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MULTI-LUMEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MULTI-LUMEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MULTI-LUMEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY SINGLE LUMEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY SINGLE LUMEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY SINGLE LUMEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY GUIDEWIRE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY GUIDEWIRE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY GUIDEWIRE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY GUIDEWIRE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HYDROPHILIC COATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HYDROPHILIC COATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HYDROPHILIC COATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY J TIP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY J TIP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY J TIP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY STRAIGHT TIP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY STRAIGHT TIP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY STRAIGHT TIP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HEMOSTASIS VALVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HEMOSTASIS VALVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HEMOSTASIS VALVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HEMOSTASIS VALVE, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HYDROPHILIC VALVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HYDROPHILIC VALVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HYDROPHILIC VALVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MECHANICAL VALVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MECHANICAL VALVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MECHANICAL VALVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY INTRODUCER SHEATH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY INTRODUCER SHEATH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY INTRODUCER SHEATH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY INTRODUCER SHEATH, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 10FR & ABOVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 10FR & ABOVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 10FR & ABOVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 6FR & BELOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 6FR & BELOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 6FR & BELOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 7FR-9FR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 7FR-9FR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 7FR-9FR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY SHEATH SIZE, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 10FR & ABOVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 10FR & ABOVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 10FR & ABOVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 6FR & BELOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 6FR & BELOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 6FR & BELOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 7FR-9FR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 7FR-9FR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 7FR-9FR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NYLON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NYLON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NYLON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NYLON, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MONOFILAMENT NYLON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MONOFILAMENT NYLON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MONOFILAMENT NYLON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MULTIFILAMENT NYLON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MULTIFILAMENT NYLON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MULTIFILAMENT NYLON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY POLYURETHANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY POLYURETHANE, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY ESTER POLYURETHANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY ESTER POLYURETHANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY ESTER POLYURETHANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY ETHER POLYURETHANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY ETHER POLYURETHANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY ETHER POLYURETHANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY PTFE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY PTFE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY PTFE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY PTFE, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY EXPANDED PTFE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY EXPANDED PTFE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY EXPANDED PTFE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY STANDARD PTFE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY STANDARD PTFE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY STANDARD PTFE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DIAGNOSTIC ANGIOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DIAGNOSTIC ANGIOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DIAGNOSTIC ANGIOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY INTERVENTIONAL CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY INTERVENTIONAL CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY INTERVENTIONAL CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROIMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROIMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROIMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROINTERVENTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROINTERVENTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROINTERVENTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY RADIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY RADIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY RADIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DIAGNOSTIC RADIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DIAGNOSTIC RADIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DIAGNOSTIC RADIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY VASCULAR SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY VASCULAR SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY VASCULAR SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY VASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY EVAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY EVAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY EVAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIAC ASC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIAC ASC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIAC ASC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY RADIOLOGY ASC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY RADIOLOGY ASC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY RADIOLOGY ASC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY OUTPATIENT CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY OUTPATIENT CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY OUTPATIENT CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIAC HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIAC HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIAC HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MULTISPECIALTY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MULTISPECIALTY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MULTISPECIALTY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 163. AMERICAS FEMORAL ACCESS DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 164. AMERICAS FEMORAL ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. AMERICAS FEMORAL ACCESS DEVICES MARKET SIZE, BY DILATOR, 2018-2032 (USD MILLION)
  • TABLE 166. AMERICAS FEMORAL ACCESS DEVICES MARKET SIZE, BY GUIDEWIRE, 2018-2032 (USD MILLION)
  • TABLE 167. AMERICAS FEMORAL ACCESS DEVICES MARKET SIZE, BY HEMOSTASIS VALVE, 2018-2032 (USD MILLION)
  • TABLE 168. AMERICAS FEMORAL ACCESS DEVICES MARKET SIZE, BY INTRODUCER SHEATH, 2018-2032 (USD MILLION)
  • TABLE 169. AMERICAS FEMORAL ACCESS DEVICES MARKET SIZE, BY SHEATH SIZE, 2018-2032 (USD MILLION)
  • TABLE 170. AMERICAS FEMORAL ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 171. AMERICAS FEMORAL ACCESS DEVICES MARKET SIZE, BY NYLON, 2018-2032 (USD MILLION)
  • TABLE 172. AMERICAS FEMORAL ACCESS DEVICES MARKET SIZE, BY POLYURETHANE, 2018-2032 (USD MILLION)
  • TABLE 173. AMERICAS FEMORAL ACCESS DEVICES MARKET SIZE, BY PTFE, 2018-2032 (USD MILLION)
  • TABLE 174. AMERICAS FEMORAL ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. AMERICAS FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 176. AMERICAS FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 177. AMERICAS FEMORAL ACCESS DEVICES MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 178. AMERICAS FEMORAL ACCESS DEVICES MARKET SIZE, BY VASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 179. AMERICAS FEMORAL ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. AMERICAS FEMORAL ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
  • TABLE 181. AMERICAS FEMORAL ACCESS DEVICES MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 182. AMERICAS FEMORAL ACCESS DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. NORTH AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY DILATOR, 2018-2032 (USD MILLION)
  • TABLE 186. NORTH AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY GUIDEWIRE, 2018-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY HEMOSTASIS VALVE, 2018-2032 (USD MILLION)
  • TABLE 188. NORTH AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY INTRODUCER SHEATH, 2018-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY SHEATH SIZE, 2018-2032 (USD MILLION)
  • TABLE 190. NORTH AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY NYLON, 2018-2032 (USD MILLION)
  • TABLE 192. NORTH AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY POLYURETHANE, 2018-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY PTFE, 2018-2032 (USD MILLION)
  • TABLE 194. NORTH AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 196. NORTH AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 198. NORTH AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY VASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. NORTH AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 202. NORTH AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 204. LATIN AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY DILATOR, 2018-2032 (USD MILLION)
  • TABLE 206. LATIN AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY GUIDEWIRE, 2018-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY HEMOSTASIS VALVE, 2018-2032 (USD MILLION)
  • TABLE 208. LATIN AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY INTRODUCER SHEATH, 2018-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY SHEATH SIZE, 2018-2032 (USD MILLION)
  • TABLE 210. LATIN AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY NYLON, 2018-2032 (USD MILLION)
  • TABLE 212. LATIN AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY POLYURETHANE, 2018-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY PTFE, 2018-2032 (USD MILLION)
  • TABLE 214. LATIN AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 216. LATIN AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 218. LATIN AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY VASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. LATIN AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 222. LATIN AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY DILATOR, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY GUIDEWIRE, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY HEMOSTASIS VALVE, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY INTRODUCER SHEATH, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY SHEATH SIZE, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY NYLON, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY POLYURETHANE, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY PTFE, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY VASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPE FEMORAL ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPE FEMORAL ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPE FEMORAL ACCESS DEVICES MARKET SIZE, BY DILATOR, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPE FEMORAL ACCESS DEVICES MARKET SIZE, BY GUIDEWIRE, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPE FEMORAL ACCESS DEVICES MARKET SIZE, BY HEMOSTASIS VALVE, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPE FEMORAL ACCESS DEVICES MARKET SIZE, BY INTRODUCER SHEATH, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPE FEMORAL ACCESS DEVICES MARKET SIZE, BY SHEATH SIZE, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPE FEMORAL ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPE FEMORAL ACCESS DEVICES MARKET SIZE, BY NYLON, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPE FEMORAL ACCESS DEVICES MARKET SIZE, BY POLYURETHANE, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPE FEMORAL ACCESS DEVICES MARKET SIZE, BY PTFE, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPE FEMORAL ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPE FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPE FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPE FEMORAL ACCESS DEVICES MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPE FEMORAL ACCESS DEVICES MARKET SIZE, BY VASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPE FEMORAL ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPE FEMORAL ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPE FEMORAL ACCESS DEVICES MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPE FEMORAL ACCESS DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 263. MIDDLE EAST FEMORAL ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 264. MIDDLE EAST FEMORAL ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. MIDDLE EAST FEMORAL ACCESS DEVICES MARKET SIZE, BY DILATOR, 2018-2032 (USD MILLION)
  • TABLE 266. MIDDLE EAST FEMORAL ACCESS DEVICES MARKET SIZE, BY GUIDEWIRE, 2018-2032 (USD MILLION)
  • TABLE 267. MIDDLE EAST FEMORAL ACCESS DEVICES MARKET SIZE, BY HEMOSTASIS VALVE, 2018-2032 (USD MILLION)
  • TABLE 268. MIDDLE EAST FEMORAL ACCESS DEVICES MARKET SIZE, BY INTRODUCER SHEATH, 2018-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST FEMORAL ACCESS DEVICES MARKET SIZE, BY SHEATH SIZE, 2018-2032 (USD MILLION)
  • TABLE 270. MIDDLE EAST FEMORAL ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 271. MIDDLE EAST FEMORAL ACCESS DEVICES MARKET SIZE, BY NYLON, 2018-2032 (USD MILLION)
  • TABLE 272. MIDDLE EAST FEMORAL ACCESS DEVICES MARKET SIZE, BY POLYURETHANE, 2018-2032 (USD MILLION)
  • TABLE 273. MIDDLE EAST FEMORAL ACCESS DEVICES MARKET SIZE, BY PTFE, 2018-2032 (USD MILLION)
  • TABLE 274. MIDDLE EAST FEMORAL ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 275. MIDDLE EAST FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 276. MIDDLE EAST FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 277. MIDDLE EAST FEMORAL ACCESS DEVICES MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 278. MIDDLE EAST FEMORAL ACCESS DEVICES MARKET SIZE, BY VASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 279. MIDDLE EAST FEMORAL ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 280. MIDDLE EAST FEMORAL ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
  • TABLE 281. MIDDLE EAST FEMORAL ACCESS DEVICES MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 282. MIDDLE EAST FEMORAL ACCESS DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 283. AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 284. AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY DILATOR, 2018-2032 (USD MILLION)
  • TABLE 286. AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY GUIDEWIRE, 2018-2032 (USD MILLION)
  • TABLE 287. AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY HEMOSTASIS VALVE, 2018-2032 (USD MILLION)
  • TABLE 288. AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY INTRODUCER SHEATH, 2018-2032 (USD MILLION)
  • TABLE 289. AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY SHEATH SIZE, 2018-2032 (USD MILLION)
  • TABLE 290. AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 291. AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY NYLON, 2018-2032 (USD MILLION)
  • TABLE 292. AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY POLYURETHANE, 2018-2032 (USD MILLION)
  • TABLE 293. AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY PTFE, 2018-2032 (USD MILLION)
  • TABLE 294. AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 295. AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 296. AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 297. AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 298. AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY VASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 299. AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 300. AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
  • TABLE 301. AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 302. AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 303. ASIA-PACIFIC FEMORAL ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 304. ASIA-PACIFIC FEMORAL ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 305. ASIA-PACIFIC FEMORAL ACCESS DEVICES MARKET SIZE, BY DILATOR, 2018-2032 (USD MILLION)
  • TABLE 306. ASIA-PACIFIC FEMORAL ACCESS DEVICES MARKET SIZE, BY GUIDEWIRE, 2018-2032 (USD MILLION)
  • TABLE 307. ASIA-PACIFIC FEMORAL ACCESS DEVICES MARKET SIZE, BY HEMOSTASIS VALVE, 2018-2032 (USD MILLION)
  • TABLE 308. ASIA-PACIFIC FEMORAL ACCESS DEVICES MARKET SIZE, BY INTRODUCER SHEATH, 2018-2032 (USD MILLION)
  • TABLE 309. ASIA-PACIFIC FEMORAL ACCESS DEVICES MARKET SIZE, BY SHEATH SIZE, 2018-2032 (USD MILLION)
  • TABLE 310. ASIA-PACIFIC FEMORAL ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 311. ASIA-PACIFIC FEMORAL ACCESS DEVICES MARKET SIZE, BY NYLON, 2018-2032 (USD MILLION)
  • TABLE 312. ASIA-PACIFIC FEMORAL ACCESS DEVICES MARKET SIZE, BY POLYURETHANE, 2018-2032 (USD MILLION)
  • TABLE 313. ASIA-PACIFIC FEMORAL ACCESS DEVICES MARKET SIZE, BY PTFE, 2018-2032 (USD MILLION)
  • TABLE 314. ASIA-PACIFIC FEMORAL ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 315. ASIA-PACIFIC FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 316. ASIA-PACIFIC FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 317. ASIA-PACIFIC FEMORAL ACCESS DEVICES MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 318. ASIA-PACIFIC FEMORAL ACCESS DEVICES MARKET SIZE, BY VASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 319. ASIA-PACIFIC FEMORAL ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 320. ASIA-PACIFIC FEMORAL ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2